The Choice Between a Therapy-Induced Long-Term Symptom and Shortened Survival Due to Prostate Cancer

European Urology

Volumn 50, Issue 2, 2006, Pages 280-289

  Hopfgarten, Thomas ^a,c   Adolfsson, Jan ^b   Henningsohn, Lars ^a,b   Onelöv, Erik ^a   Steineck, Gunnar ^a,d  

^a Division of Cardiovascular Epidemiology   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fecal leakage; Prostate cancer; Trade off

Indexed keywords

ANTIANDROGEN; GONADORELIN;

ADULT; AGED; ARTICLE; BREAST HYPERTROPHY; BREAST TENDERNESS; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; DIET RESTRICTION; ERECTILE DYSFUNCTION; FECES INCONTINENCE; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT INFORMATION; POSTAL MAIL; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SURVIVAL TIME; SYMPTOM; URINE INCONTINENCE;

AGED; CHI-SQUARE DISTRIBUTION; CHOICE BEHAVIOR; HUMANS; LIFE EXPECTANCY; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGISTRIES; SURVIVAL RATE; SWEDEN;

EID: 33745861710     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.12.038     Document Type: Article

References (25)

1. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
2. Steineck G., Helgesen F., Adolfsson J., et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 347 (2002) 790-796
3. Hedestig O., Sandman P.O., and Widmark A. Living with untreated localized prostate cancer: a qualitative analysis of patient narratives. Cancer Nurs 26 (2003) 55-60
4. al Abany M., Helgason A.R., Cronqvist A.K., Svensson C., Wersall P., and Steineck G. Long-term symptoms after external beam radiation therapy for prostate cancer with three or four fields. Acta Oncol 41 (2002) 532-542
5. Paule B. Reappraisal of the concept of hormone therapy in metastatic prostate cancer and implications for treatment. Eur Urol 47 (2005) 729-735
6. Widmark A., Fransson P., and Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 74 (1994) 2520-2532
7. Steineck G., Bergmark K., Henningsohn L., al Abany M., Dickman P.W., and Helgason A. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol 41 (2002) 244-252
8. Bergmark K., Åvall-Lundqvist E., Dickman P.W., Henningsohn L., and Steineck G. Vaginal changes and sexuality in women with a history of cervical cancer. N Engl J Med 340 (1999) 1383-1389
9. Bergmark K., Åvall-Lundqvist E., Dickman P.W., Henningsohn L., and Steineck G. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 81 (2002) 443-450
10. Augustsson K., Lindblad J., Övervik E., and Steineck G. A population-based dietary inventory of cooked meat and assessment of the daily intake of food mutagens. Food Addit Contam 16 (1999) 215-225
11. Henningsohn L., Wijkström H., Dickman P.W., Bergmark K., Steineck G., and Zelefsky M.J. Distressful symptoms after radical radiotherapy for urinary bladder cancer. Urol Oncol 21 (2003) 310-311
12. Rothman K.J., and Greenland S. Modern epidemiology. ed. 2 (1998), Lippincott Williams & Wilkins, Philadelphia
13. Siegel T., Moul J.W., Spevak M., Alvord W.G., and Costabile R.A. The development of erectile dysfunction in men treated for prostate cancer. J Urol 165 (2001) 430-435
14. Singer P.A., Tasch E.S., Stocking C., Rubin S., Siegler M., and Weichselbaum R. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol 9 (1991) 328-334
15. Helgason A.R., Adolfsson J., Dickman P., Fredrikson M., Arver S., and Steineck G. Waning sexual function-the most important disease-specific distress for patients with prostate cancer. Br J Cancer 73 (1996) 1417-1421
16. Saigal C.S., Gornbein J., Nease R., and Litwin M.S. Predictors of utilities for health states in early stage prostate cancer. J Urol 166 (2001) 942-946
17. Adolfsson J., Helgason A.R., Dickman P., and Steineck G. Urinary and bowel symptoms in men with and without prostate cancer: results from an observational study in the Stockholm area. Eur Urol 33 (1998) 11-16
18. Bacon C.G., Giovannucci E., Testa M., and Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 166 (2001) 1804-1810
19. Bacon C.G., Giovannucci E., Testa M., Glass T.A., and Kawachi I. The association of treatment-related symptoms with quality-of-life outcomes for localized prostate carcinoma patients. Cancer 94 (2002) 862-871
20. Fowler Jr. F.J., Barry M.J., Lu-Yao G., Roman A., Wasson J., and Wennberg J.E. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988-1990 (updated June 1993). Urology 42 (1993) 622-629
21. Augustsson K., Michaud D.S., Rimm E.B., et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomarkers Prev 12 (2003) 64-67
22. Andersson S.O., Wolk A., Bergström R., et al. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89 (1997) 385-389
23. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., and Willett W.C. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6 (1997) 557-563
24. Wolk A., Mantzoros C.S., Andersson S.O., et al. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst 90 (1998) 911-915
25. Månsson A., Henningsohn L., Steineck G., and Månsson W. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol 46 (2004) 195-199